CAPR (Capricor Therapeutics Inc)
Insider Trading Activity
Every open-market purchase and sale reported by CAPR officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-29 | Karen Krasney | EVP, GENERAL COUNSEL | MIXED | — | — |
| 2026-06-29 | Anthony Bergmann | CHIEF FINANCIAL OFFICER | MIXED | — | — |
| 2026-06-24 | Anthony Bergmann | CHIEF FINANCIAL OFFICER | MIXED | — | — |
| 2026-06-24 | Karen Krasney | EVP, GENERAL COUNSEL | MIXED | — | — |
| 2026-05-28 | Michael T Maurer | CHIEF COMMERCIAL OFFICER | A | — | — |
| 2026-05-19 | Anthony Bergmann | CHIEF FINANCIAL OFFICER | M | — | — |
| 2026-05-14 | Frank Litvack | Director | M | — | — |
| 2026-05-04 | Anthony Bergmann | CHIEF FINANCIAL OFFICER | MIXED | — | — |
| 2026-05-04 | Karen Krasney | EVP, GENERAL COUNSEL | MIXED | — | — |
| 2026-04-03 | Karimah Es Sabar | Director | MIXED | — | — |
| 2026-04-01 | Karen Krasney | EVP, GENERAL COUNSEL | MIXED | — | — |
| 2026-04-01 | Anthony Bergmann | CHIEF FINANCIAL OFFICER | MIXED | — | — |
| 2026-04-01 | Karimah Es Sabar | Director | MIXED | — | — |
| 2026-03-27 | Karen Krasney | EVP, GENERAL COUNSEL | M | — | — |
| 2026-01-07 | Linda Marban | CHIEF EXECUTIVE OFFICER | A | — | — |
| 2026-01-07 | David B Musket | Director | A | — | — |
| 2026-01-07 | Philip J Gotwals | Director | A | — | — |
| 2026-01-07 | GEORGE W DUNBAR JR | Director | A | — | — |
| 2026-01-07 | Anthony Bergmann | CHIEF FINANCIAL OFFICER | A | — | — |
| 2026-01-07 | Paul Gisbert Auwaerter | Director | A | — | — |
| 2026-01-07 | Karen Krasney | EVP, GENERAL COUNSEL | A | — | — |
| 2026-01-07 | Frank Litvack | Director | A | — | — |
| 2026-01-07 | Mike Kelliher | Director | A | — | — |
| 2026-01-07 | Karimah Es Sabar | Director | A | — | — |
| 2025-12-23 | GEORGE W DUNBAR JR | Director | M | — | — |
| 2025-03-05 | Linda Marban | CHIEF EXECUTIVE OFFICER | MIXED | — | — |
| 2025-03-04 | Anthony Bergmann | CHIEF FINANCIAL OFFICER | M | — | — |
| 2025-03-04 | Frank Litvack | Director | MIXED | — | — |
| 2025-03-04 | GEORGE W DUNBAR JR | Director | M | — | — |
| 2025-02-28 | EARL M COLLIER JR | Director | M | — | — |
| 2025-01-06 | Mike Kelliher | Director | A | — | — |
| 2025-01-06 | Karimah Es Sabar | Director | A | — | — |
| 2025-01-06 | Frank Litvack | Director | A | — | — |
| 2025-01-06 | Paul Gisbert Auwaerter | Director | A | — | — |
| 2025-01-06 | EARL M COLLIER JR | Director | A | — | — |
| 2025-01-06 | David B Musket | Director | A | — | — |
| 2025-01-06 | Anthony Bergmann | CHIEF FINANCIAL OFFICER | A | — | — |
| 2025-01-06 | Philip J Gotwals | Director | A | — | — |
| 2025-01-06 | GEORGE W DUNBAR JR | Director | A | — | — |
| 2025-01-06 | Karen Krasney | EVP, GENERAL COUNSEL | A | — | — |
| 2025-01-06 | Linda Marban | CHIEF EXECUTIVE OFFICER | A | — | — |
| 2024-12-16 | Karen Krasney | EVP, GENERAL COUNSEL | M | — | — |
| 2024-12-04 | Frank Litvack | Director | M | — | — |
| 2024-09-24 | Nippon Shinyaku Co Ltd | 10%+ Owner | Buy | — | — |
| 2024-08-09 | David B Musket | Director | M | — | — |
| 2024-04-25 | EARL M COLLIER JR | Director | M | — | — |
| 2024-04-24 | David B Musket | Director | M | — | — |
| 2024-01-04 | Frank Litvack | Director | A | — | — |
| 2024-01-04 | EARL M COLLIER JR | Director | A | — | — |
| 2024-01-04 | Philip J Gotwals | Director | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | 10%+ Owner | 7,090,351 | — |
| — | CHIEF EXECUTIVE OFFICER | 533,519 | — |
| — | 10%+ Owner | 404,996 | — |
| — | 10%+ Owner | 343,351 | — |
| — | 10%+ Owner | 239,858 | — |
| — | Director | 180,054 | — |
| — | Director | 126,414 | — |
| — | Director | 113,676 | — |
| — | Director | 88,788 | — |
| — | Director | 57,606 | — |
| — | EVP, GENERAL COUNSEL | 54,647 | — |
| — | Director | 14,306 | — |
| — | CHIEF FINANCIAL OFFICER | 11,223 | — |
| — | Director | 5,000 | — |
| — | Vice President of R&D | 1,850 | — |
| — | CHIEF FINANCIAL OFFICER | 210 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the CAPR quote page; the site-wide leaderboard is on the insider transactions hub.